CADM1 and ocular melanoma: One notable difference between use of FBS or PL was that in OM-PL RUNX2 expression was more significantly covariant with other biomarker genes, namely BGN, CADM1, COL1A1 and ELN at two weeks and BGN, COL1A1 and ELN at one week (Table 4).